Department of Immunology, Beaumont Hospital, Dublin, Ireland.
Department of Immunology, St James's Hospital and Trinity College Dublin, Dublin, Ireland.
J Clin Pharmacol. 2021 Jun;61(6):832-835. doi: 10.1002/jcph.1824. Epub 2021 Feb 28.
Polyethylene glycol (PEG), also known as macrogol, is an excipient in numerous medications, health care products, cosmetics, and foods. It acts as an inert bulking, or stabilizing, agent. Despite its ubiquity, including in 2 of the newly launched vaccines against SARS-CoV-2, awareness of PEG allergy remains low. We present 6 cases of acute hypersensitivity to PEG. Accurate diagnoses in these cases posed a challenge, and although the triggering agents differed, PEG was demonstrated as the common culprit. All cases were female, with a mean age of 36.4 years. Four patients were originally suspected to have nonsteroid anti-inflammatory drug allergy, and 2 had a history of chronic spontaneous urticaria and angioedema. Biphasic allergic reactions featured prominently in this case series. Diagnosis relies on a high index of suspicion leading to a focused clinical history, supported by skin tests with PEG solutions to demonstrate sensitization. This case series highlights important clinical features of this rare, potentially serious, and increasingly recognized excipient allergy.
聚乙二醇(PEG),也称为聚氧化乙烯,是许多药物、保健品、化妆品和食品中的赋形剂。它作为一种惰性的填充或稳定剂。尽管它无处不在,包括在最近推出的两种针对 SARS-CoV-2 的疫苗中,但对 PEG 过敏的认识仍然很低。我们报告了 6 例对 PEG 的急性过敏反应。这些病例的准确诊断带来了挑战,尽管触发因素不同,但 PEG 被证明是共同的罪魁祸首。所有病例均为女性,平均年龄为 36.4 岁。4 例患者最初被怀疑对非甾体抗炎药过敏,2 例有慢性自发性荨麻疹和血管性水肿病史。双相过敏反应在本病例系列中占主导地位。诊断依赖于高度怀疑导致集中的临床病史,并通过 PEG 溶液的皮肤试验来证明致敏。本病例系列强调了这种罕见、潜在严重且越来越被认识到的赋形剂过敏的重要临床特征。